These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 35300626

  • 1. Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.
    Kamai T, Murakami S, Arai K, Nishihara D, Uematsu T, Ishida K, Kijima T.
    BMC Cancer; 2022 Mar 18; 22(1):289. PubMed ID: 35300626
    [Abstract] [Full Text] [Related]

  • 2. The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.
    Udager AM, Magers MJ, Goerke DM, Vinco ML, Siddiqui J, Cao X, Lucas DR, Myers JL, Chinnaiyan AM, McHugh JB, Giordano TJ, Else T, Mehra R.
    Hum Pathol; 2018 Jan 18; 71():47-54. PubMed ID: 29079178
    [Abstract] [Full Text] [Related]

  • 3. Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
    Rai SK, Bril F, Hatch HM, Xu Y, Shelton L, Kalavalapalli S, Click A, Lee D, Beecher C, Kirby A, Kong K, Trevino J, Jha A, Jatav S, Kriti K, Luthra S, Garrett TJ, Guingab-Cagmat J, Plant D, Bose P, Cusi K, Hromas RA, Tischler AS, Powers JF, Gupta P, Bibb J, Beuschlein F, Robledo M, Calsina B, Timmers H, Taieb D, Kroiss M, Richter S, Langton K, Eisenhofer G, Bergeron R, Pacak K, Tevosian SG, Ghayee HK.
    Metabolism; 2020 Sep 18; 110():154297. PubMed ID: 32562798
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic status determines 18 F-FDG uptake in pheochromocytoma/paraganglioma.
    Tiwari A, Shah N, Sarathi V, Malhotra G, Bakshi G, Prakash G, Khadilkar K, Pandit R, Lila A, Bandgar T.
    J Med Imaging Radiat Oncol; 2017 Dec 18; 61(6):745-752. PubMed ID: 28585398
    [Abstract] [Full Text] [Related]

  • 7. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
    Gupta S, Zhang J, Milosevic D, Mills JR, Grebe SK, Smith SC, Erickson LA.
    Endocr Pathol; 2017 Sep 18; 28(3):253-268. PubMed ID: 28646318
    [Abstract] [Full Text] [Related]

  • 8. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
    Jochmanova I, Wolf KI, King KS, Nambuba J, Wesley R, Martucci V, Raygada M, Adams KT, Prodanov T, Fojo AT, Lazurova I, Pacak K.
    J Cancer Res Clin Oncol; 2017 Aug 18; 143(8):1421-1435. PubMed ID: 28374168
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas.
    Castelblanco E, Santacana M, Valls J, de Cubas A, Cascón A, Robledo M, Matias-Guiu X.
    Endocr Pathol; 2013 Dec 18; 24(4):199-205. PubMed ID: 24096807
    [Abstract] [Full Text] [Related]

  • 11. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T, Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Reynolds JC, Ling A, Eisenhofer G, Lazúrová I, Adams KT, Whatley MA, Widimsky J, Pacak K.
    Endocr Relat Cancer; 2008 Mar 18; 15(1):311-23. PubMed ID: 18310297
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH, Dwight T, Benn DE, Meyer-Rochow GY, Gill AJ, Sywak M, Sidhu S, Veivers D, Sue CM, Robinson BG, Clifton-Bligh RJ, Parker NR.
    Endocr Relat Cancer; 2014 Jun 18; 21(3):415-26. PubMed ID: 24623741
    [Abstract] [Full Text] [Related]

  • 13. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
    Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams KT, Solis D, Lenders JW, Pacak K.
    J Clin Oncol; 2007 Jun 01; 25(16):2262-9. PubMed ID: 17538171
    [Abstract] [Full Text] [Related]

  • 14. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
    Castro-Vega LJ, Buffet A, De Cubas AA, Cascón A, Menara M, Khalifa E, Amar L, Azriel S, Bourdeau I, Chabre O, Currás-Freixes M, Franco-Vidal V, Guillaud-Bataille M, Simian C, Morin A, Letón R, Gómez-Graña A, Pollard PJ, Rustin P, Robledo M, Favier J, Gimenez-Roqueplo AP.
    Hum Mol Genet; 2014 May 01; 23(9):2440-6. PubMed ID: 24334767
    [Abstract] [Full Text] [Related]

  • 15. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.
    Fishbein L, Khare S, Wubbenhorst B, DeSloover D, D'Andrea K, Merrill S, Cho NW, Greenberg RA, Else T, Montone K, LiVolsi V, Fraker D, Daber R, Cohen DL, Nathanson KL.
    Nat Commun; 2015 Jan 21; 6():6140. PubMed ID: 25608029
    [Abstract] [Full Text] [Related]

  • 16. SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis.
    Su T, Yang Y, Jiang L, Xie J, Zhong X, Wu L, Jiang Y, Zhang C, Zhou W, Ye L, Ning G, Wang W.
    Front Endocrinol (Lausanne); 2023 Jan 21; 14():1121397. PubMed ID: 37008946
    [Abstract] [Full Text] [Related]

  • 17. Germline FH mutations presenting with pheochromocytoma.
    Clark GR, Sciacovelli M, Gaude E, Walsh DM, Kirby G, Simpson MA, Trembath RC, Berg JN, Woodward ER, Kinning E, Morrison PJ, Frezza C, Maher ER.
    J Clin Endocrinol Metab; 2014 Oct 21; 99(10):E2046-50. PubMed ID: 25004247
    [Abstract] [Full Text] [Related]

  • 18. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
    Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J, Latif F, Gleeson MJ, Hodgson SV, Stamp GW, Tomlinson IP, Maher ER.
    J Clin Endocrinol Metab; 2006 Nov 21; 91(11):4593-8. PubMed ID: 16954163
    [Abstract] [Full Text] [Related]

  • 19. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C, European-American Paraganglioma Study Group.
    JAMA; 2004 Aug 25; 292(8):943-51. PubMed ID: 15328326
    [Abstract] [Full Text] [Related]

  • 20. The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study.
    Schovanek J, Martucci V, Wesley R, Fojo T, Del Rivero J, Huynh T, Adams K, Kebebew E, Frysak Z, Stratakis CA, Pacak K.
    BMC Cancer; 2014 Jul 21; 14():523. PubMed ID: 25048685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.